Startups
About nOH Matters
nOH Matters was created for the purpose of enabling people with nOH to share their personal experiences in order to educate, support, and inspire each other. Follow the conversation to learn from others like you, get helpful tips about living with nOH, discover support events and activities, and connect with leading advocacy organizations.
About Lundbeck
Lundbeck is a global pharmaceutical company dedicated to providing innovative therapies to fulfill unmet needs of people living with psychiatric and neurological disorders.
As a pioneer for therapies of psychiatric and neurological disorders for more than 70 years, Lundbeck has been committed to developing and providing innovative therapies that help improve the quality of life in patients. This is important work because the burden of neurological and psychiatric disorders remains substantial. When we assess a medical condition, we see the person behind the disease and how it affects the lives of patients, their families, their caregivers and their communities.
Follow us on Twitter at @LundbeckUS.
Terms of Use & Community Rules
We look forward to engaging with the nOH community and invite you to participate in the conversation. As a pharmaceutical company, we operate in a highly regulated industry and must adhere to certain laws and regulations. Therefore, all comments submitted to our page must be monitored and reviewed and may be subject to removal. To help ensure that your comments will be taken into consideration and posted, please adhere to the following community rules:
Do not include:
•Offensive, defamatory or obscene language;
•Any reference to pharmaceutical products, treatments or questions related to medical advice;
•Information to pitch products or services;
•Any adverse events or side effect possibly due to a medication.
Instead, any adverse event concerns should be reported immediately to http://www.fda.gov/medwatch or by calling 1-800-FDA-1088.
Comments must clearly relate to Lundbeck’s discussion topic. Any posts or comments submitted become the property of Lundbeck.
This Facebook page is intended for U.S. residents only. All comments shared are not necessarily reflective of Lundbeck. We reserve the right to update our community rules or remove this page, or any of its comments, at any time.
Any information provided here is not a substitute for medical advice from a healthcare professional. Always visit or speak to a qualified healthcare professional in person regarding your medical condition.
http://www.lundbeck.com/us/terms-of-use-and-privacy-policy#policyhttp://www.lundbeck.com/us/terms-of-use-and-privacy-policy#terms
Website: http://www/lundbeck.com/us
UBR-D-00343(2)
nOH Matters was created for the purpose of enabling people with nOH to share their personal experiences in order to educate, support, and inspire each other. Follow the conversation to learn from others like you, get helpful tips about living with nOH, discover support events and activities, and connect with leading advocacy organizations.
About Lundbeck
Lundbeck is a global pharmaceutical company dedicated to providing innovative therapies to fulfill unmet needs of people living with psychiatric and neurological disorders.
As a pioneer for therapies of psychiatric and neurological disorders for more than 70 years, Lundbeck has been committed to developing and providing innovative therapies that help improve the quality of life in patients. This is important work because the burden of neurological and psychiatric disorders remains substantial. When we assess a medical condition, we see the person behind the disease and how it affects the lives of patients, their families, their caregivers and their communities.
Follow us on Twitter at @LundbeckUS.
Terms of Use & Community Rules
We look forward to engaging with the nOH community and invite you to participate in the conversation. As a pharmaceutical company, we operate in a highly regulated industry and must adhere to certain laws and regulations. Therefore, all comments submitted to our page must be monitored and reviewed and may be subject to removal. To help ensure that your comments will be taken into consideration and posted, please adhere to the following community rules:
Do not include:
•Offensive, defamatory or obscene language;
•Any reference to pharmaceutical products, treatments or questions related to medical advice;
•Information to pitch products or services;
•Any adverse events or side effect possibly due to a medication.
Instead, any adverse event concerns should be reported immediately to http://www.fda.gov/medwatch or by calling 1-800-FDA-1088.
Comments must clearly relate to Lundbeck’s discussion topic. Any posts or comments submitted become the property of Lundbeck.
This Facebook page is intended for U.S. residents only. All comments shared are not necessarily reflective of Lundbeck. We reserve the right to update our community rules or remove this page, or any of its comments, at any time.
Any information provided here is not a substitute for medical advice from a healthcare professional. Always visit or speak to a qualified healthcare professional in person regarding your medical condition.
http://www.lundbeck.com/us/terms-of-use-and-privacy-policy#policyhttp://www.lundbeck.com/us/terms-of-use-and-privacy-policy#terms
Website: http://www/lundbeck.com/us
UBR-D-00343(2)
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 24, 2021 | National Rare Disease Day: Recognizing Neurogenic Orthostatic Hypotension | (BPT) - In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people. Each year on February 28, the rare disease community joins together on Rare Disease Day to raise awareness of as many as 7,000 ra... |
| National Rare Disease Day: Recognizing Neurogenic Orthostatic Hypotension | (BPT) - In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people. Each year on February 28, the rare disease community joins together on Rare Disease Day to raise awareness of as many as 7,000 ra... |
Reviews 0
FAQ about nOH Matters
What has the press written about nOH Matters?
Parsers VC has collected 3 articles mentioning nOH Matters, among them “National Rare Disease Day: Recognizing Neurogenic Orthostatic Hypotension” (Feb 24, 2021) and “National Rare Disease Day: Recognizing Neurogenic Orthostatic Hypotension”.
Is nOH Matters still active?
Yes, nOH Matters is active; its latest activity on Parsers VC dates from May 14, 2021.